Fentanyl kills by shutting down the brain’s automatic drive to breathe. It is up to 100 times stronger than morphine and 50 times stronger than heroin, meaning a dose as small as 2 milligrams can be fatal depending on a person’s size and tolerance. In 2024, synthetic opioids like fentanyl were still involved in roughly 47,700 overdose deaths in the United States, even after a significant decline from the previous year’s 72,776.
How Fentanyl Stops Breathing
Your body breathes without you thinking about it because a cluster of neurons deep in the brainstem generates a constant rhythm, sending signals to your diaphragm and chest muscles. Fentanyl binds to receptors on these neurons called mu-opioid receptors. When fentanyl latches on, it triggers a chain of events inside each cell: potassium channels open (which quiets the neuron), and calcium channels close (which prevents the neuron from signaling to its neighbors). The net effect is that the neurons responsible for breathing rhythm slow down and, at high enough doses, stop firing altogether.
This respiratory depression is what makes every opioid dangerous at high doses, but fentanyl’s extreme potency means the margin between a dose that produces a high and a dose that stops breathing is razor-thin. A person can go from conscious to not breathing in minutes. Without oxygen, the heart eventually stops, and brain damage begins within four to six minutes.
Wooden Chest Syndrome
Fentanyl can also cause a lesser-known effect called chest wall rigidity, sometimes called “wooden chest syndrome.” The muscles of the chest and abdomen become so stiff that the person physically cannot expand their lungs, even if the brainstem is still trying to drive breathing. This has been documented in clinical settings where fentanyl was administered under medical supervision, and it likely contributes to deaths in illicit use as well. It creates a situation where even bystander rescue breathing becomes extremely difficult because the chest simply won’t move.
Why Such a Tiny Amount Is Lethal
Fentanyl’s potency comes from its chemical structure, which lets it cross into the brain faster and bind more tightly to opioid receptors than older drugs like heroin or morphine. The DEA considers 2 milligrams a potentially lethal dose for someone without opioid tolerance. For reference, 2 milligrams is roughly the weight of a few grains of table salt. This makes precise dosing nearly impossible outside of a pharmaceutical lab, and it’s the core reason the illicit supply is so deadly.
Carfentanil, a fentanyl analog originally developed as a tranquilizer for elephants, is approximately 100 times more potent than fentanyl itself, or about 10,000 times more potent than morphine. It has appeared in the illicit drug supply in some regions, where even trace contamination of a batch can be fatal.
Counterfeit Pills and Unpredictable Doses
A major driver of fentanyl deaths is that people often don’t know they’re taking it. Fentanyl is pressed into counterfeit pills designed to look like prescription painkillers, benzodiazepines, or other medications. DEA lab testing found that 6 out of 10 fentanyl-laced counterfeit pills contain a potentially lethal dose, up from 4 out of 10 just a year earlier. Because fentanyl isn’t distributed evenly through a batch of powder, two pills from the same bag can contain wildly different amounts. One might produce mild effects while the next causes a fatal overdose.
This inconsistency is what separates fentanyl from earlier waves of the opioid crisis. With heroin or prescription pills, experienced users could roughly gauge their dose. With illicitly manufactured fentanyl, there is no way to estimate potency by appearance, taste, or smell.
Xylazine Makes Overdoses Harder to Survive
The illicit fentanyl supply increasingly contains xylazine, a veterinary sedative that is not an opioid. When combined with fentanyl, xylazine doesn’t just add to the sedation; the two drugs interact synergistically, meaning their combined lethality is greater than you’d expect from simply adding their individual effects together. In animal studies, a dose of fentanyl that was not lethal on its own reduced the lethal threshold for xylazine by roughly fivefold.
This matters for overdose reversal because xylazine’s effects don’t respond to naloxone, the standard opioid antidote. Naloxone can still reverse the fentanyl component and is worth administering, but the person may remain dangerously sedated from the xylazine even after naloxone is given.
Why Naloxone Sometimes Isn’t Enough
Naloxone works by knocking opioids off the same brain receptors fentanyl occupies. With heroin or prescription opioids, a single standard dose of naloxone is usually enough to restore breathing. Fentanyl changes that equation. Because fentanyl binds so aggressively and reaches such high concentrations in the brain during an overdose, naloxone needs to outcompete a much larger number of occupied receptors. Multiple doses are frequently required, and some researchers have argued that the standard recommended doses of naloxone are simply not high enough for the current era of synthetic opioids.
There’s also a timing problem. Fentanyl acts so fast that a person can stop breathing before anyone realizes what’s happening. And because naloxone wears off faster than fentanyl does, a person who initially responds to naloxone can slip back into respiratory depression 30 to 90 minutes later if they don’t receive medical attention.
The Scale of the Crisis
Synthetic opioids, predominantly illicit fentanyl and its analogs, drove roughly 47,700 deaths in the U.S. in 2024, a rate of 14.3 per 100,000 people. That represents a 35.6% decline from 2023, when the rate was 22.2 per 100,000. While the drop is significant, fentanyl still accounts for more overdose deaths than any other single drug category. The decline likely reflects a combination of wider naloxone distribution, increased awareness, and shifts in the drug supply, but the numbers remain staggering by any historical standard.